For the third time this year, the US Securities and Exchange Commission
is being urged to investigate allegations of whether Elon Musk made
misleading claims to investors about the deaths of primates used for
research by Neuralink, his brain-chip startup.
The latest claims center around his recent statements at the New York
Times DealBook Summit that primates who died after implant surgeries
were selected for experimentation because they were already close to
death. In a letter sent to federal regulators today, an animal rights
advocacy and research group claims that Musk’s statements are inaccurate
and amount to “possible securities fraud.”
The most recent letter, written by the Physicians Committee for
Responsible Medicine, centers on an interview between Musk and Times
financial columnist Andrew Ross Sorkin on November 29. Asked to respond
to reports of the gruesome deaths that occurred during early Neuralink experiments at UC Davis, Musk told the audience that the monkeys who
endured experimental surgeries were already terminal. “It’s the kind of thing which we could only put in a monkey that’s about to die,” he said, referring to his experimental chip, adding, “It didn’t die because of
the Neuralink, it died because it had a terminal case of cancer or
something like that.”
The Physicians Committee’s letter alleges that there is no proof that primates had fatal conditions before receiving implants. Citing
veterinary records the organization obtained last year, the letter
claims that Neuralink scientists performed experimental surgeries on
previously healthy primates, some of which went on to suffer
complications ranging from serious fungal infections to loosely
implanted chips to bleeding or swelling in their brain.
https://www.wired.com/story/elon-musk-neuralink-dealbook-comments-sec/
Monkeys died because of "something like that"!? Absolutely zero pwinciples.
--
"And off they went, from here to there,
The bear, the bear, and the maiden fair"
-- Traditional
--- SoupGate-Win32 v1.05
* Origin: fsxNet Usenet Gateway (21:1/5)